Patent details

Basic Information

Publication number:

EP3009129

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151931789

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PEPTIDE PHARMACEUTICAL FOR ORAL DELIVERY

French Title of Invention:

PEPTIDE PHARMACEUTIQUE POUR ADMINISTRATION ORALE

German Title of Invention:

PEPTIDARZNEIMITTEL FÜR ORALE ABGABE

SPC Number:

Dates

Filing date:

29/05/2008

Grant date:

09/08/2017

EP Publication Date:

20/04/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/08/2017

EP B1 Publication Date:

09/08/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/05/2018

Expiration date:

29/05/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/08/2017

 

 

Name:

Enteris BioPharma, Inc.

Address:

83 Fulton Street, Boonton, NJ 07005, United States (US)

Inventor

1

Name:

Consalvo, Angelo P.

Address:

United States (US)

2

Name:

Stern, William

Address:

United States (US)

Priority

1

Priority Number:

940598 P

Priority Date:

29/05/2007

Priority Country:

United States (US)

2

Priority Number:

128210

Priority Date:

28/05/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/16; A61K 9/20; A61K 9/28; A61K 9/50; A61K 38/23; A61K 38/29;

Publication

European Patent Bulletin

Issue number:

201732

Publication date:

09/08/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/09/2018	Outgoing Correspondence	1